API5 Knockout Cell Line (HEK293)

The choice depends on the experimental question. API5 (apoptosis inhibitor 5, AAC-11) is a less-characterized factor with reported anti-apoptotic functions and emerging functions in cancer. The Knockout line is appropriate for asking whether API5 is required for predicted activities — API5 has been characterized as an anti-apoptotic factor regulated by serum, with reported binding to FGF2 and Acinus; API5 overexpression has been reported in cancers and correlates with chemotherapy resistance. Overexpression is useful for studying API5 gain-of-function effects. For cancer biology research, the EDITGENE API5 Knockout in HEK293 provides a clean genetic background for characterizing API5-specific functions. Rescue with wild-type API5 is the standard specificity control. The knockout is valuable for studying API5-mediated apoptosis suppression, chemotherapy resistance mechanisms, and emerging API5-related cancer biology.

Primary applications: • Apoptosis sensitivity: serum withdrawal-induced apoptosis sensitivity in API5-null cells given anti-apoptotic role. • Chemotherapy resistance: cisplatin, doxorubicin sensitivity analysis given API5's reported chemoresistance role. • FGF2/Acinus interactions: API5-FGF2 and API5-Acinus partnership analysis. • Discovery proteomics: interactome analysis in API5-null versus rescued cells. EDITGENE recommends this model for researchers investigating API5-mediated cancer cell survival and chemoresistance.

Yes. API5 rescue experiments require attention to less-characterized protein architecture: • Construct design: use a codon-modified API5 sequence with a small C-terminal tag (FLAG, HA). API5 has leucine zipper-like domain — preserve protein integrity. • Discovery-oriented rescue: parallel wild-type rescue during phenotypic characterization distinguishes API5-dependent phenotypes. • Functional readout: rescue should restore API5-dependent apoptosis suppression. HEK293 transduces efficiently with lentivirus and supports stable rescue line generation.